Holland M R, Venable M E, Whatley R E, Zimmerman G A, McIntyre T M, Prescott S M
Nora Eccles Harrison Cardiovascular Research and Training Institute, Salt Lake City, Utah.
J Biol Chem. 1992 Nov 15;267(32):22883-90.
Platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) is a phospholipid with many physiological actions. It is synthesized by endothelial cells and a variety of others in response to stimulation with receptor-mediated agonists. In endothelial cells it remains associated with the surface of the cell and serves as a signal for adhesive interactions with leukocytes. Thus, its synthesis must be precisely regulated. In previous work we have shown that PAF synthesis is regulated at the initiating step, a phospholipase A2. Here we demonstrate that the subsequent step of PAF synthesis, the acetyl-CoA:lyso-PAF acetyltransferase, is rapidly activated when cells are exposed to thrombin or other agonists. We found that the activity increased from basal values (5 nmol/mg/min) to approximately 3-fold higher within 1 min following the addition of agonists. The enzyme activity returned to basal levels within 10 min. The pattern of activation and inactivation suggested covalent modification of the enzyme. This was supported in experiments in which we showed that homogenates had stable enhanced activity and that there was no evidence for an activator or inhibitor. Pretreatment of the cells with vanadate, an inhibitor of protein phosphatases, markedly prolonged the activation state. In subsequent studies we pretreated intact cells with vanadate to block inactivation of the enzyme and then measured the accumulation of PAF in response to thrombin. We found that it was markedly augmented and prolonged. From this we conclude that the synthesis of PAF in intact cells is regulated by the activity of the acetyltransferase. We characterized requirements for activation of acetyltransferase and found that it was not dependent on the influx of intracellular calcium but that calcium entry did influence the length of time for which the enzyme was activated. The acetyltransferase in endothelial cells was shown to be a specific enzyme that did not catalyze the transfer of long chain acyl groups from acyl-CoA to lysophospholipids and demonstrated modest specificity for the acceptor lysophospholipids. These results suggest that activation of the acetyltransferase is a crucial determinant of the amount of PAF synthesized in activated endothelial cells.
血小板活化因子(1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱;PAF)是一种具有多种生理作用的磷脂。它由内皮细胞和其他多种细胞在受体介导的激动剂刺激下合成。在内皮细胞中,它仍与细胞表面结合,并作为与白细胞黏附相互作用的信号。因此,其合成必须受到精确调控。在先前的研究中,我们已经表明PAF合成在起始步骤,即磷脂酶A2处受到调控。在此我们证明,当细胞暴露于凝血酶或其他激动剂时,PAF合成的后续步骤,即乙酰辅酶A:溶血PAF乙酰转移酶会迅速被激活。我们发现,在添加激动剂后1分钟内,该酶的活性从基础值(5 nmol/mg/分钟)增加到约3倍。酶活性在10分钟内恢复到基础水平。这种激活和失活模式提示该酶发生了共价修饰。这在实验中得到了支持,我们发现匀浆具有稳定增强的活性,并且没有证据表明存在激活剂或抑制剂。用钒酸盐(一种蛋白磷酸酶抑制剂)预处理细胞,可显著延长激活状态。在随后的研究中,我们用钒酸盐预处理完整细胞以阻断该酶的失活,然后测量凝血酶刺激下PAF的积累。我们发现其显著增加且持续时间延长。由此我们得出结论,完整细胞中PAF的合成受乙酰转移酶活性的调控。我们确定了乙酰转移酶激活的条件,发现其不依赖于细胞内钙的流入,但钙的进入确实会影响该酶被激活的时间长度。内皮细胞中的乙酰转移酶被证明是一种特异性酶,它不催化长链酰基从酰基辅酶A转移到溶血磷脂,并且对受体溶血磷脂表现出适度的特异性。这些结果表明,乙酰转移酶的激活是激活的内皮细胞中PAF合成量的关键决定因素。